Accessibility settings

This paper is in the following e-collection/theme issue:

Diabetes Prevention (170) Prevention and Health Promotion (2310) Obesity and Nutrition as Public Health Problem (605) Gastroenterology and Hepatology (208)

Published on in Vol 10 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/77772, first published .
Doctor performing abdominal ultrasound on a patient.

Prevalence and Risk Factors of Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study

Prevalence and Risk Factors of Metabolic Dysfunction–Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study

Authors of this article:

Abdulrahman M Elnasieh1 Author Orcid Image ;   Mohammed Almesned1 Author Orcid Image ;   Akram N Al Hazmi1 Author Orcid Image ;   Atheer Alturki1 Author Orcid Image ;   Faisal I Alhawaidi1 Author Orcid Image ;   Razan K Alhadlq1 Author Orcid Image ;   Maryam Alramadhan2 Author Orcid Image ;   Nasser Alobilan2 Author Orcid Image ;   Yasser Sheikh Qroosh3 Author Orcid Image
Article Authors Cited by (2) Tweetations Metrics

Journals

  1. Aydagnuhm G, Tefera A, Getahun G, Melaku E. Predictive factors of metabolic dysfunction associated steatotic liver disease (MASLD) among individuals with cardio-metabolic risk factors, multicenter cross-sectional study, North East Ethiopia. BMC Gastroenterology 2026;26(1) View
  2. Altarrah M, Alhammad R, Ahmad S, Abu-Farha M, Devarajan S, Alhaddad S, Afyoni A, AlHaifi F, Qaddoumi M, Shehab M, Salah M, Ali H, Abdul Ghani M, Al-Mulla F, Alajmi F, Abubaker J. Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait. Frontiers in Endocrinology 2026;17 View